nodes	percent_of_prediction	percent_of_DWPC	metapath
Hyoscyamine—Depression—Vandetanib—thyroid cancer	0.00607	0.00607	CcSEcCtD
Hyoscyamine—Eczema—Sorafenib—thyroid cancer	0.00592	0.00592	CcSEcCtD
Hyoscyamine—Conjunctivitis—Vandetanib—thyroid cancer	0.00591	0.00591	CcSEcCtD
Hyoscyamine—Bradycardia—Vandetanib—thyroid cancer	0.00556	0.00556	CcSEcCtD
Hyoscyamine—Hyponatraemia—Sorafenib—thyroid cancer	0.00535	0.00535	CcSEcCtD
Hyoscyamine—Dehydration—Sorafenib—thyroid cancer	0.00495	0.00495	CcSEcCtD
Hyoscyamine—Blindness—Epirubicin—thyroid cancer	0.0049	0.0049	CcSEcCtD
Hyoscyamine—Dry skin—Sorafenib—thyroid cancer	0.00488	0.00488	CcSEcCtD
Hyoscyamine—Arrhythmia—Vandetanib—thyroid cancer	0.00488	0.00488	CcSEcCtD
Hyoscyamine—Hypokalaemia—Sorafenib—thyroid cancer	0.00485	0.00485	CcSEcCtD
Hyoscyamine—Mental disorder—Vandetanib—thyroid cancer	0.00478	0.00478	CcSEcCtD
Hyoscyamine—Dysgeusia—Vandetanib—thyroid cancer	0.00465	0.00465	CcSEcCtD
Hyoscyamine—Dysphagia—Sorafenib—thyroid cancer	0.0046	0.0046	CcSEcCtD
Hyoscyamine—Blindness—Doxorubicin—thyroid cancer	0.00453	0.00453	CcSEcCtD
Hyoscyamine—Vision blurred—Vandetanib—thyroid cancer	0.00448	0.00448	CcSEcCtD
Hyoscyamine—Erectile dysfunction—Sorafenib—thyroid cancer	0.00424	0.00424	CcSEcCtD
Hyoscyamine—Keratitis—Epirubicin—thyroid cancer	0.00418	0.00418	CcSEcCtD
Hyoscyamine—Loss of consciousness—Vandetanib—thyroid cancer	0.00418	0.00418	CcSEcCtD
Hyoscyamine—Convulsion—Vandetanib—thyroid cancer	0.00412	0.00412	CcSEcCtD
Hyoscyamine—Chest pain—Vandetanib—thyroid cancer	0.00405	0.00405	CcSEcCtD
Hyoscyamine—Acute coronary syndrome—Sorafenib—thyroid cancer	0.00404	0.00404	CcSEcCtD
Hyoscyamine—Anxiety—Vandetanib—thyroid cancer	0.00403	0.00403	CcSEcCtD
Hyoscyamine—Myocardial infarction—Sorafenib—thyroid cancer	0.00402	0.00402	CcSEcCtD
Hyoscyamine—Dry mouth—Vandetanib—thyroid cancer	0.00396	0.00396	CcSEcCtD
Hyoscyamine—Paralysis—Epirubicin—thyroid cancer	0.0039	0.0039	CcSEcCtD
Hyoscyamine—Oedema—Vandetanib—thyroid cancer	0.00388	0.00388	CcSEcCtD
Hyoscyamine—Keratitis—Doxorubicin—thyroid cancer	0.00387	0.00387	CcSEcCtD
Hyoscyamine—Laryngitis—Epirubicin—thyroid cancer	0.00376	0.00376	CcSEcCtD
Hyoscyamine—Ventricular arrhythmia—Epirubicin—thyroid cancer	0.00366	0.00366	CcSEcCtD
Hyoscyamine—Paralysis—Doxorubicin—thyroid cancer	0.00361	0.00361	CcSEcCtD
Hyoscyamine—Rash erythematous—Epirubicin—thyroid cancer	0.00354	0.00354	CcSEcCtD
Hyoscyamine—Insomnia—Vandetanib—thyroid cancer	0.00351	0.00351	CcSEcCtD
Hyoscyamine—Laryngitis—Doxorubicin—thyroid cancer	0.00348	0.00348	CcSEcCtD
Hyoscyamine—Dyspnoea—Vandetanib—thyroid cancer	0.00346	0.00346	CcSEcCtD
Hyoscyamine—Feeling hot—Epirubicin—thyroid cancer	0.00345	0.00345	CcSEcCtD
Hyoscyamine—Flushing—Sorafenib—thyroid cancer	0.00342	0.00342	CcSEcCtD
Hyoscyamine—Dyspepsia—Vandetanib—thyroid cancer	0.00341	0.00341	CcSEcCtD
Hyoscyamine—Ventricular arrhythmia—Doxorubicin—thyroid cancer	0.00339	0.00339	CcSEcCtD
Hyoscyamine—Ageusia—Epirubicin—thyroid cancer	0.00335	0.00335	CcSEcCtD
Hyoscyamine—Stinging—Epirubicin—thyroid cancer	0.00335	0.00335	CcSEcCtD
Hyoscyamine—Fatigue—Vandetanib—thyroid cancer	0.00334	0.00334	CcSEcCtD
Hyoscyamine—Pain—Vandetanib—thyroid cancer	0.00332	0.00332	CcSEcCtD
Hyoscyamine—Constipation—Vandetanib—thyroid cancer	0.00332	0.00332	CcSEcCtD
Hyoscyamine—Petechiae—Epirubicin—thyroid cancer	0.00329	0.00329	CcSEcCtD
Hyoscyamine—Arrhythmia—Sorafenib—thyroid cancer	0.00329	0.00329	CcSEcCtD
Hyoscyamine—Rash erythematous—Doxorubicin—thyroid cancer	0.00328	0.00328	CcSEcCtD
Hyoscyamine—Blood disorder—Epirubicin—thyroid cancer	0.00325	0.00325	CcSEcCtD
Hyoscyamine—Mental disorder—Sorafenib—thyroid cancer	0.00323	0.00323	CcSEcCtD
Hyoscyamine—Erythema—Sorafenib—thyroid cancer	0.00321	0.00321	CcSEcCtD
Hyoscyamine—Feeling hot—Doxorubicin—thyroid cancer	0.0032	0.0032	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00317	0.00317	CcSEcCtD
Hyoscyamine—Delirium—Epirubicin—thyroid cancer	0.00315	0.00315	CcSEcCtD
Hyoscyamine—Dysgeusia—Sorafenib—thyroid cancer	0.00314	0.00314	CcSEcCtD
Hyoscyamine—Stinging—Doxorubicin—thyroid cancer	0.0031	0.0031	CcSEcCtD
Hyoscyamine—Ageusia—Doxorubicin—thyroid cancer	0.0031	0.0031	CcSEcCtD
Hyoscyamine—Abdominal pain—Vandetanib—thyroid cancer	0.00307	0.00307	CcSEcCtD
Hyoscyamine—Body temperature increased—Vandetanib—thyroid cancer	0.00307	0.00307	CcSEcCtD
Hyoscyamine—Petechiae—Doxorubicin—thyroid cancer	0.00305	0.00305	CcSEcCtD
Hyoscyamine—Blood disorder—Doxorubicin—thyroid cancer	0.003	0.003	CcSEcCtD
Hyoscyamine—Ventricular extrasystoles—Epirubicin—thyroid cancer	0.003	0.003	CcSEcCtD
Hyoscyamine—Angioedema—Sorafenib—thyroid cancer	0.00293	0.00293	CcSEcCtD
Hyoscyamine—Delirium—Doxorubicin—thyroid cancer	0.00292	0.00292	CcSEcCtD
Hyoscyamine—Syncope—Sorafenib—thyroid cancer	0.00288	0.00288	CcSEcCtD
Hyoscyamine—Dysarthria—Epirubicin—thyroid cancer	0.00287	0.00287	CcSEcCtD
Hyoscyamine—Loss of consciousness—Sorafenib—thyroid cancer	0.00282	0.00282	CcSEcCtD
Hyoscyamine—Asthenia—Vandetanib—thyroid cancer	0.00278	0.00278	CcSEcCtD
Hyoscyamine—Ventricular extrasystoles—Doxorubicin—thyroid cancer	0.00278	0.00278	CcSEcCtD
Hyoscyamine—Pruritus—Vandetanib—thyroid cancer	0.00274	0.00274	CcSEcCtD
Hyoscyamine—Ventricular tachycardia—Epirubicin—thyroid cancer	0.00271	0.00271	CcSEcCtD
Hyoscyamine—Injection site reaction—Epirubicin—thyroid cancer	0.00269	0.00269	CcSEcCtD
Hyoscyamine—Dermatitis contact—Epirubicin—thyroid cancer	0.00268	0.00268	CcSEcCtD
Hyoscyamine—Dry mouth—Sorafenib—thyroid cancer	0.00267	0.00267	CcSEcCtD
Hyoscyamine—Diarrhoea—Vandetanib—thyroid cancer	0.00265	0.00265	CcSEcCtD
Hyoscyamine—Dysarthria—Doxorubicin—thyroid cancer	0.00265	0.00265	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Sorafenib—thyroid cancer	0.00262	0.00262	CcSEcCtD
Hyoscyamine—Skin exfoliation—Epirubicin—thyroid cancer	0.00259	0.00259	CcSEcCtD
Hyoscyamine—Shock—Sorafenib—thyroid cancer	0.00257	0.00257	CcSEcCtD
Hyoscyamine—Dizziness—Vandetanib—thyroid cancer	0.00257	0.00257	CcSEcCtD
Hyoscyamine—Blood urea increased—Epirubicin—thyroid cancer	0.00256	0.00256	CcSEcCtD
Hyoscyamine—Ventricular tachycardia—Doxorubicin—thyroid cancer	0.00251	0.00251	CcSEcCtD
Hyoscyamine—Dry eye—Epirubicin—thyroid cancer	0.0025	0.0025	CcSEcCtD
Hyoscyamine—Injection site reaction—Doxorubicin—thyroid cancer	0.00249	0.00249	CcSEcCtD
Hyoscyamine—Dermatitis contact—Doxorubicin—thyroid cancer	0.00248	0.00248	CcSEcCtD
Hyoscyamine—Coma—Epirubicin—thyroid cancer	0.00248	0.00248	CcSEcCtD
Hyoscyamine—Vomiting—Vandetanib—thyroid cancer	0.00247	0.00247	CcSEcCtD
Hyoscyamine—Rash maculo-papular—Epirubicin—thyroid cancer	0.00246	0.00246	CcSEcCtD
Hyoscyamine—Rash—Vandetanib—thyroid cancer	0.00245	0.00245	CcSEcCtD
Hyoscyamine—Dermatitis—Vandetanib—thyroid cancer	0.00244	0.00244	CcSEcCtD
Hyoscyamine—Headache—Vandetanib—thyroid cancer	0.00243	0.00243	CcSEcCtD
Hyoscyamine—Pulmonary oedema—Epirubicin—thyroid cancer	0.00241	0.00241	CcSEcCtD
Hyoscyamine—Skin exfoliation—Doxorubicin—thyroid cancer	0.00239	0.00239	CcSEcCtD
Hyoscyamine—Hypertonia—Epirubicin—thyroid cancer	0.00238	0.00238	CcSEcCtD
Hyoscyamine—Blood urea increased—Doxorubicin—thyroid cancer	0.00237	0.00237	CcSEcCtD
Hyoscyamine—Dyspnoea—Sorafenib—thyroid cancer	0.00233	0.00233	CcSEcCtD
Hyoscyamine—Dry eye—Doxorubicin—thyroid cancer	0.00232	0.00232	CcSEcCtD
Hyoscyamine—Nausea—Vandetanib—thyroid cancer	0.0023	0.0023	CcSEcCtD
Hyoscyamine—Dyspepsia—Sorafenib—thyroid cancer	0.0023	0.0023	CcSEcCtD
Hyoscyamine—Coma—Doxorubicin—thyroid cancer	0.00229	0.00229	CcSEcCtD
Hyoscyamine—Rash maculo-papular—Doxorubicin—thyroid cancer	0.00228	0.00228	CcSEcCtD
Hyoscyamine—Fatigue—Sorafenib—thyroid cancer	0.00226	0.00226	CcSEcCtD
Hyoscyamine—Constipation—Sorafenib—thyroid cancer	0.00224	0.00224	CcSEcCtD
Hyoscyamine—Pain—Sorafenib—thyroid cancer	0.00224	0.00224	CcSEcCtD
Hyoscyamine—Pulmonary oedema—Doxorubicin—thyroid cancer	0.00223	0.00223	CcSEcCtD
Hyoscyamine—Hypertonia—Doxorubicin—thyroid cancer	0.0022	0.0022	CcSEcCtD
Hyoscyamine—Eczema—Epirubicin—thyroid cancer	0.00219	0.00219	CcSEcCtD
Hyoscyamine—Eye pain—Epirubicin—thyroid cancer	0.00218	0.00218	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00214	0.00214	CcSEcCtD
Hyoscyamine—Urticaria—Sorafenib—thyroid cancer	0.00208	0.00208	CcSEcCtD
Hyoscyamine—Abdominal pain—Sorafenib—thyroid cancer	0.00207	0.00207	CcSEcCtD
Hyoscyamine—Body temperature increased—Sorafenib—thyroid cancer	0.00207	0.00207	CcSEcCtD
Hyoscyamine—Eczema—Doxorubicin—thyroid cancer	0.00203	0.00203	CcSEcCtD
Hyoscyamine—Eye pain—Doxorubicin—thyroid cancer	0.00202	0.00202	CcSEcCtD
Hyoscyamine—Hypoglycaemia—Epirubicin—thyroid cancer	0.00202	0.00202	CcSEcCtD
Hyoscyamine—Lethargy—Epirubicin—thyroid cancer	0.00201	0.00201	CcSEcCtD
Hyoscyamine—Hyponatraemia—Epirubicin—thyroid cancer	0.00198	0.00198	CcSEcCtD
Hyoscyamine—Osteoarthritis—Epirubicin—thyroid cancer	0.00197	0.00197	CcSEcCtD
Hyoscyamine—Hypersensitivity—Sorafenib—thyroid cancer	0.00193	0.00193	CcSEcCtD
Hyoscyamine—Asthenia—Sorafenib—thyroid cancer	0.00188	0.00188	CcSEcCtD
Hyoscyamine—Cardiac arrest—Epirubicin—thyroid cancer	0.00187	0.00187	CcSEcCtD
Hyoscyamine—Hypoglycaemia—Doxorubicin—thyroid cancer	0.00187	0.00187	CcSEcCtD
Hyoscyamine—Lethargy—Doxorubicin—thyroid cancer	0.00186	0.00186	CcSEcCtD
Hyoscyamine—Pruritus—Sorafenib—thyroid cancer	0.00185	0.00185	CcSEcCtD
Hyoscyamine—Ataxia—Epirubicin—thyroid cancer	0.00185	0.00185	CcSEcCtD
Hyoscyamine—Dehydration—Epirubicin—thyroid cancer	0.00183	0.00183	CcSEcCtD
Hyoscyamine—Hyponatraemia—Doxorubicin—thyroid cancer	0.00183	0.00183	CcSEcCtD
Hyoscyamine—Osteoarthritis—Doxorubicin—thyroid cancer	0.00182	0.00182	CcSEcCtD
Hyoscyamine—Dry skin—Epirubicin—thyroid cancer	0.0018	0.0018	CcSEcCtD
Hyoscyamine—Hypokalaemia—Epirubicin—thyroid cancer	0.00179	0.00179	CcSEcCtD
Hyoscyamine—Diarrhoea—Sorafenib—thyroid cancer	0.00179	0.00179	CcSEcCtD
Hyoscyamine—Cardiac arrest—Doxorubicin—thyroid cancer	0.00173	0.00173	CcSEcCtD
Hyoscyamine—Dizziness—Sorafenib—thyroid cancer	0.00173	0.00173	CcSEcCtD
Hyoscyamine—Abdominal distension—Epirubicin—thyroid cancer	0.00171	0.00171	CcSEcCtD
Hyoscyamine—Ataxia—Doxorubicin—thyroid cancer	0.00171	0.00171	CcSEcCtD
Hyoscyamine—Dysphagia—Epirubicin—thyroid cancer	0.0017	0.0017	CcSEcCtD
Hyoscyamine—Dehydration—Doxorubicin—thyroid cancer	0.00169	0.00169	CcSEcCtD
Hyoscyamine—Dry skin—Doxorubicin—thyroid cancer	0.00167	0.00167	CcSEcCtD
Hyoscyamine—Vomiting—Sorafenib—thyroid cancer	0.00166	0.00166	CcSEcCtD
Hyoscyamine—Hypokalaemia—Doxorubicin—thyroid cancer	0.00166	0.00166	CcSEcCtD
Hyoscyamine—Angina pectoris—Epirubicin—thyroid cancer	0.00166	0.00166	CcSEcCtD
Hyoscyamine—Rash—Sorafenib—thyroid cancer	0.00165	0.00165	CcSEcCtD
Hyoscyamine—Dermatitis—Sorafenib—thyroid cancer	0.00165	0.00165	CcSEcCtD
Hyoscyamine—Headache—Sorafenib—thyroid cancer	0.00164	0.00164	CcSEcCtD
Hyoscyamine—Dysuria—Epirubicin—thyroid cancer	0.00159	0.00159	CcSEcCtD
Hyoscyamine—Abdominal distension—Doxorubicin—thyroid cancer	0.00158	0.00158	CcSEcCtD
Hyoscyamine—Dysphagia—Doxorubicin—thyroid cancer	0.00157	0.00157	CcSEcCtD
Hyoscyamine—Nausea—Sorafenib—thyroid cancer	0.00155	0.00155	CcSEcCtD
Hyoscyamine—Hyperglycaemia—Epirubicin—thyroid cancer	0.00153	0.00153	CcSEcCtD
Hyoscyamine—Angina pectoris—Doxorubicin—thyroid cancer	0.00153	0.00153	CcSEcCtD
Hyoscyamine—Drowsiness—Epirubicin—thyroid cancer	0.00152	0.00152	CcSEcCtD
Hyoscyamine—Conjunctivitis—Epirubicin—thyroid cancer	0.00147	0.00147	CcSEcCtD
Hyoscyamine—Dysuria—Doxorubicin—thyroid cancer	0.00147	0.00147	CcSEcCtD
Hyoscyamine—Sweating—Epirubicin—thyroid cancer	0.00145	0.00145	CcSEcCtD
Hyoscyamine—Hyperglycaemia—Doxorubicin—thyroid cancer	0.00142	0.00142	CcSEcCtD
Hyoscyamine—Drowsiness—Doxorubicin—thyroid cancer	0.0014	0.0014	CcSEcCtD
Hyoscyamine—Bradycardia—Epirubicin—thyroid cancer	0.00139	0.00139	CcSEcCtD
Hyoscyamine—Conjunctivitis—Doxorubicin—thyroid cancer	0.00136	0.00136	CcSEcCtD
Hyoscyamine—Sweating—Doxorubicin—thyroid cancer	0.00135	0.00135	CcSEcCtD
Hyoscyamine—Bradycardia—Doxorubicin—thyroid cancer	0.00128	0.00128	CcSEcCtD
Hyoscyamine—Flushing—Epirubicin—thyroid cancer	0.00126	0.00126	CcSEcCtD
Hyoscyamine—Arrhythmia—Epirubicin—thyroid cancer	0.00122	0.00122	CcSEcCtD
Hyoscyamine—Mental disorder—Epirubicin—thyroid cancer	0.00119	0.00119	CcSEcCtD
Hyoscyamine—Erythema—Epirubicin—thyroid cancer	0.00119	0.00119	CcSEcCtD
Hyoscyamine—Flushing—Doxorubicin—thyroid cancer	0.00117	0.00117	CcSEcCtD
Hyoscyamine—Tension—Epirubicin—thyroid cancer	0.00116	0.00116	CcSEcCtD
Hyoscyamine—Dysgeusia—Epirubicin—thyroid cancer	0.00116	0.00116	CcSEcCtD
Hyoscyamine—Nervousness—Epirubicin—thyroid cancer	0.00115	0.00115	CcSEcCtD
Hyoscyamine—Arrhythmia—Doxorubicin—thyroid cancer	0.00113	0.00113	CcSEcCtD
Hyoscyamine—Vision blurred—Epirubicin—thyroid cancer	0.00112	0.00112	CcSEcCtD
Hyoscyamine—Mental disorder—Doxorubicin—thyroid cancer	0.0011	0.0011	CcSEcCtD
Hyoscyamine—Erythema—Doxorubicin—thyroid cancer	0.0011	0.0011	CcSEcCtD
Hyoscyamine—Agitation—Epirubicin—thyroid cancer	0.00109	0.00109	CcSEcCtD
Hyoscyamine—Tension—Doxorubicin—thyroid cancer	0.00108	0.00108	CcSEcCtD
Hyoscyamine—Dysgeusia—Doxorubicin—thyroid cancer	0.00107	0.00107	CcSEcCtD
Hyoscyamine—Nervousness—Doxorubicin—thyroid cancer	0.00106	0.00106	CcSEcCtD
Hyoscyamine—Vertigo—Epirubicin—thyroid cancer	0.00106	0.00106	CcSEcCtD
Hyoscyamine—Syncope—Epirubicin—thyroid cancer	0.00106	0.00106	CcSEcCtD
Hyoscyamine—Palpitations—Epirubicin—thyroid cancer	0.00105	0.00105	CcSEcCtD
Hyoscyamine—Loss of consciousness—Epirubicin—thyroid cancer	0.00104	0.00104	CcSEcCtD
Hyoscyamine—Vision blurred—Doxorubicin—thyroid cancer	0.00103	0.00103	CcSEcCtD
Hyoscyamine—Convulsion—Epirubicin—thyroid cancer	0.00103	0.00103	CcSEcCtD
Hyoscyamine—Chest pain—Epirubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Hyoscyamine—Agitation—Doxorubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Hyoscyamine—Anxiety—Epirubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Hyoscyamine—Dry mouth—Epirubicin—thyroid cancer	0.000987	0.000987	CcSEcCtD
Hyoscyamine—Vertigo—Doxorubicin—thyroid cancer	0.000985	0.000985	CcSEcCtD
Hyoscyamine—Syncope—Doxorubicin—thyroid cancer	0.000983	0.000983	CcSEcCtD
Hyoscyamine—Confusional state—Epirubicin—thyroid cancer	0.000975	0.000975	CcSEcCtD
Hyoscyamine—Palpitations—Doxorubicin—thyroid cancer	0.000969	0.000969	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Epirubicin—thyroid cancer	0.000967	0.000967	CcSEcCtD
Hyoscyamine—Oedema—Epirubicin—thyroid cancer	0.000967	0.000967	CcSEcCtD
Hyoscyamine—Loss of consciousness—Doxorubicin—thyroid cancer	0.000964	0.000964	CcSEcCtD
Hyoscyamine—Shock—Epirubicin—thyroid cancer	0.000952	0.000952	CcSEcCtD
Hyoscyamine—Convulsion—Doxorubicin—thyroid cancer	0.00095	0.00095	CcSEcCtD
Hyoscyamine—Tachycardia—Epirubicin—thyroid cancer	0.000944	0.000944	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Epirubicin—thyroid cancer	0.000935	0.000935	CcSEcCtD
Hyoscyamine—Chest pain—Doxorubicin—thyroid cancer	0.000933	0.000933	CcSEcCtD
Hyoscyamine—Anxiety—Doxorubicin—thyroid cancer	0.00093	0.00093	CcSEcCtD
Hyoscyamine—Dry mouth—Doxorubicin—thyroid cancer	0.000913	0.000913	CcSEcCtD
Hyoscyamine—Hypotension—Epirubicin—thyroid cancer	0.000904	0.000904	CcSEcCtD
Hyoscyamine—Confusional state—Doxorubicin—thyroid cancer	0.000902	0.000902	CcSEcCtD
Hyoscyamine—Oedema—Doxorubicin—thyroid cancer	0.000895	0.000895	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000895	0.000895	CcSEcCtD
Hyoscyamine—Shock—Doxorubicin—thyroid cancer	0.00088	0.00088	CcSEcCtD
Hyoscyamine—Insomnia—Epirubicin—thyroid cancer	0.000875	0.000875	CcSEcCtD
Hyoscyamine—Tachycardia—Doxorubicin—thyroid cancer	0.000873	0.000873	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000865	0.000865	CcSEcCtD
Hyoscyamine—Dyspnoea—Epirubicin—thyroid cancer	0.000862	0.000862	CcSEcCtD
Hyoscyamine—Somnolence—Epirubicin—thyroid cancer	0.00086	0.00086	CcSEcCtD
Hyoscyamine—Dyspepsia—Epirubicin—thyroid cancer	0.000851	0.000851	CcSEcCtD
Hyoscyamine—Hypotension—Doxorubicin—thyroid cancer	0.000836	0.000836	CcSEcCtD
Hyoscyamine—Fatigue—Epirubicin—thyroid cancer	0.000834	0.000834	CcSEcCtD
Hyoscyamine—Pain—Epirubicin—thyroid cancer	0.000827	0.000827	CcSEcCtD
Hyoscyamine—Constipation—Epirubicin—thyroid cancer	0.000827	0.000827	CcSEcCtD
Hyoscyamine—Insomnia—Doxorubicin—thyroid cancer	0.000809	0.000809	CcSEcCtD
Hyoscyamine—Dyspnoea—Doxorubicin—thyroid cancer	0.000798	0.000798	CcSEcCtD
Hyoscyamine—Feeling abnormal—Epirubicin—thyroid cancer	0.000797	0.000797	CcSEcCtD
Hyoscyamine—Somnolence—Doxorubicin—thyroid cancer	0.000796	0.000796	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000791	0.000791	CcSEcCtD
Hyoscyamine—Dyspepsia—Doxorubicin—thyroid cancer	0.000788	0.000788	CcSEcCtD
Hyoscyamine—Fatigue—Doxorubicin—thyroid cancer	0.000772	0.000772	CcSEcCtD
Hyoscyamine—Urticaria—Epirubicin—thyroid cancer	0.000768	0.000768	CcSEcCtD
Hyoscyamine—Pain—Doxorubicin—thyroid cancer	0.000765	0.000765	CcSEcCtD
Hyoscyamine—Constipation—Doxorubicin—thyroid cancer	0.000765	0.000765	CcSEcCtD
Hyoscyamine—Abdominal pain—Epirubicin—thyroid cancer	0.000765	0.000765	CcSEcCtD
Hyoscyamine—Body temperature increased—Epirubicin—thyroid cancer	0.000765	0.000765	CcSEcCtD
Hyoscyamine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000737	0.000737	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000732	0.000732	CcSEcCtD
Hyoscyamine—Hypersensitivity—Epirubicin—thyroid cancer	0.000713	0.000713	CcSEcCtD
Hyoscyamine—Urticaria—Doxorubicin—thyroid cancer	0.000711	0.000711	CcSEcCtD
Hyoscyamine—Body temperature increased—Doxorubicin—thyroid cancer	0.000707	0.000707	CcSEcCtD
Hyoscyamine—Abdominal pain—Doxorubicin—thyroid cancer	0.000707	0.000707	CcSEcCtD
Hyoscyamine—Asthenia—Epirubicin—thyroid cancer	0.000694	0.000694	CcSEcCtD
Hyoscyamine—Pruritus—Epirubicin—thyroid cancer	0.000684	0.000684	CcSEcCtD
Hyoscyamine—Diarrhoea—Epirubicin—thyroid cancer	0.000662	0.000662	CcSEcCtD
Hyoscyamine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000659	0.000659	CcSEcCtD
Hyoscyamine—Asthenia—Doxorubicin—thyroid cancer	0.000642	0.000642	CcSEcCtD
Hyoscyamine—Dizziness—Epirubicin—thyroid cancer	0.00064	0.00064	CcSEcCtD
Hyoscyamine—Pruritus—Doxorubicin—thyroid cancer	0.000633	0.000633	CcSEcCtD
Hyoscyamine—Vomiting—Epirubicin—thyroid cancer	0.000615	0.000615	CcSEcCtD
Hyoscyamine—Diarrhoea—Doxorubicin—thyroid cancer	0.000612	0.000612	CcSEcCtD
Hyoscyamine—Rash—Epirubicin—thyroid cancer	0.00061	0.00061	CcSEcCtD
Hyoscyamine—Dermatitis—Epirubicin—thyroid cancer	0.000609	0.000609	CcSEcCtD
Hyoscyamine—Headache—Epirubicin—thyroid cancer	0.000606	0.000606	CcSEcCtD
Hyoscyamine—Dizziness—Doxorubicin—thyroid cancer	0.000592	0.000592	CcSEcCtD
Hyoscyamine—Nausea—Epirubicin—thyroid cancer	0.000574	0.000574	CcSEcCtD
Hyoscyamine—Vomiting—Doxorubicin—thyroid cancer	0.000569	0.000569	CcSEcCtD
Hyoscyamine—Rash—Doxorubicin—thyroid cancer	0.000564	0.000564	CcSEcCtD
Hyoscyamine—Dermatitis—Doxorubicin—thyroid cancer	0.000564	0.000564	CcSEcCtD
Hyoscyamine—Headache—Doxorubicin—thyroid cancer	0.000561	0.000561	CcSEcCtD
Hyoscyamine—Nausea—Doxorubicin—thyroid cancer	0.000532	0.000532	CcSEcCtD
